Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(13):920-931; doi:10.1093/jnci/djj246
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Pischon, T.
Right arrow Articles by Riboli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pischon, T.
Right arrow Articles by Riboli, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

ARTICLE

Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)

Tobias Pischon, Petra H. Lahmann, Heiner Boeing, Christine Friedenreich, Teresa Norat, Anne Tjønneland, Jytte Halkjaer, Kim Overvad, Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, Gregory Guernec, Manuela M. Bergmann, Jakob Linseisen, Nikolaus Becker, Antonia Trichopoulou, Dimitrios Trichopoulos, Sabina Sieri, Domenico Palli, Rosario Tumino, Paolo Vineis, Salvatore Panico, Petra H. M. Peeters, H. Bas Bueno-de-Mesquita, Hendriek C. Boshuizen, Bethany Van Guelpen, Richard Palmqvist, Göran Berglund, Carlos Alberto Gonzalez, Miren Dorronsoro, Aurelio Barricarte, Carmen Navarro, Carmen Martinez, J. Ramón Quirós, Andrew Roddam, Naomi Allen, Sheila Bingham, Kay-Tee Khaw, Pietro Ferrari, Rudolf Kaaks, Nadia Slimani, Elio Riboli

Affiliations of authors: Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany (TP, PHL, HB, MMB); Division of Population Health and Information, Alberta Cancer Board, Calgary, Alberta, Canada (CF); International Agency for Research on Cancer, Lyon, France (TN, PF, RK, NS, ER); Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark (A. Tjønneland, JH); Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark (KO); INSERM U 521, Institut Gustave Roussy, Villejuif, France (FCC, MCBR, GG); Division of Clinical Epidemiology, German Cancer Research Center, Heidelberg, Germany (JL, NB); Department of Hygiene and Epidemiology, School of Medicine, University of Athens, Athens, Greece (A. Trichopoulou, DT); Epidemiology Unit, National Cancer Institute, Milan, Italy (SS); Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Florence, Italy (DP); Cancer Registry, Azienda Ospedaliera "Civile M.P. Arezzo," Ragusa, Italy (RT); Imperial College London, UK, and University of Torino, Turin, Italy (PV); Dipartimento di Medicina Clinica e Sperimentale, Università di Napoli, Naples, Italy (SP); Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (PHMP); Center for Nutrition and Health (HBBdM), Center for Information Technology and Informatics (HCB), National Institute of Public Health and the Environment, Bilthoven, The Netherlands; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden (BVG, RP); Department of Medicine, Lund University, Malmö, Sweden (GB); Department of Epidemiology, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain (CAG); Department of Public Health of Guipuzkoa, San Sebastian, Spain (MD); Public Health Institute of Navarra, Pamplona, Spain (AB); Epidemiology Department, Murcia Health Council, Murcia, Spain (CN); Escuela Andaluza de Salud Publica, Granada, Spain (CM); Health Information Unit, Public Health and Health Planning Directorate, Asturias, Spain (JRQ); Cancer Research UK Epidemiology Unit, University of Oxford, Oxford, UK (AR, NA); Dunn Human Nutrition Unit, Medical Research Council, Cambridge, UK (SB); Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK (KTK)

Correspondence to: Tobias Pischon, MD, MPH, Department of Epidemiology, German Institute of Human Nutrition (DIfE), Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114–116, 14558 Nuthetal, Germany (e-mail: pischon{at}mail.dife.de).

Background: Body weight and body mass index (BMI) are positively related to risk of colon cancer in men, whereas weak or no associations exist in women. This discrepancy may be related to differences in fat distribution between sexes or to the use of hormone replacement therapy (HRT) in women. Methods: We used multivariable adjusted Cox proportional hazards models to examine the association between anthropometric measures and risks of colon and rectal cancer among 368 277 men and women who were free of cancer at baseline from nine countries of the European Prospective Investigation Into Cancer and Nutrition. All statistical tests were two-sided. Results: During 6.1 years of follow-up, we identified 984 and 586 patients with colon and rectal cancer, respectively. Body weight and BMI were statistically significantly associated with colon cancer risk in men (highest versus lowest quintile of BMI, relative risk [RR] = 1.55, 95% confidence interval [CI] = 1.12 to 2.15; Ptrend = .006) but not in women. In contrast, comparisons of the highest to the lowest quintile showed that several anthropometric measures, including waist circumference (men, RR = 1.39, 95% CI = 1.01 to 1.93; Ptrend = .001; women, RR = 1.48, 95% CI = 1.08 to 2.03; Ptrend = .008), waist-to-hip ratio (WHR; men, RR = 1.51, 95% CI = 1.06 to 2.15; Ptrend = .006; women, RR = 1.52, 95% CI = 1.12 to 2.05; Ptrend = .002), and height (men, RR = 1.40, 95% CI = 0.99 to 1.98; Ptrend = .04; women, RR = 1.79, 95% CI = 1.30 to 2.46; Ptrend<.001) were related to colon cancer risk in both sexes. The estimated absolute risk of developing colon cancer within 5 years was 203 and 131 cases per 100 000 men and 129 and 86 cases per 100 000 women in the highest and lowest quintiles of WHR, respectively. Upon further stratification, no association of waist circumference and WHR with risk of colon cancer was observed among postmenopausal women who used HRT. None of the anthropometric measures was statistically significantly related to rectal cancer. Conclusions: Waist circumference and WHR, indicators of abdominal obesity, were strongly associated with colon cancer risk in men and women in this population. The association of abdominal obesity with colon cancer risk may vary depending on HRT use in postmenopausal women; however, these findings require confirmation in future studies.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Schizophr BullHome page
M. V. Seeman
Secondary Effects of Antipsychotics: Women at Greater Risk Than Men
Schizophr Bull, April 9, 2008; (2008) sbn023v1.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
C. Sauvaget, K. Ramadas, G. Thomas, J. Vinoda, S. Thara, and R. Sankaranarayanan
Body mass index, weight change and mortality risk in a prospective study in India
Int. J. Epidemiol., April 3, 2008; (2008) dyn059v1.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Kuijsten, P. C. H. Hollman, H. C. Boshuizen, M. N. C. P. Buijsman, P. van 't Veer, F. J. Kok, I. C. W. Arts, and H. B. Bueno-de-Mesquita
Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study
Am. J. Epidemiol., March 15, 2008; 167(6): 734 - 742.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. J Williams, N. Mitsiades, E. Sozopoulos, A. Hsi, A. Wolk, A.-P. Nifli, S. Tseleni-Balafouta, and C. S Mantzoros
Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors
Endocr. Relat. Cancer, March 1, 2008; 15(1): 289 - 299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Wardle, S. Carnell, C. M. Haworth, and R. Plomin
Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment
Am. J. Clinical Nutrition, February 1, 2008; 87(2): 398 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. A. Moghaddam, M. Woodward, and R. Huxley
Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2533 - 2547.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. K Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, D. Bull, and Million Women Study Collaboration
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
BMJ, December 1, 2007; 335(7630): 1134 - 1134.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
E. E Calle
Obesity and cancer
BMJ, December 1, 2007; 335(7630): 1107 - 1108.
[Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson
Body shape throughout life and correlations with IGFs and GH
Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. C Larsson and A. Wolk
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Giovannucci
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 836S - 842S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. T. Campbell, M. Cotterchio, E. Dicks, P. Parfrey, S. Gallinger, and J. R. McLaughlin
Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1735 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-P. Lu, B. Nolan, Y.-R. Lou, Q.-Y. Peng, G. C. Wagner, and A. H. Conney
Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice
PNAS, July 31, 2007; 104(31): 12936 - 12941.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
K. F. Adams, M. F. Leitzmann, D. Albanes, V. Kipnis, T. Mouw, A. Hollenbeck, and A. Schatzkin
Body Mass and Colorectal Cancer Risk in the NIH-AARP Cohort
Am. J. Epidemiol., July 1, 2007; 166(1): 36 - 45.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. A. Wolf, P. D. Terry, J. D. Potter, and R. M. Bostick
Do Factors Related to Endogenous and Exogenous Estrogens Modify the Relationship between Obesity and Risk of Colorectal Adenomas in Women?
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 676 - 683.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.